GeoffreyWChanMD

Oncology • Collegeville, PA

Hematologic Oncology

Physician

Join to view full profile

Dr. Chan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chan's full profile

Already have an account?

Office
1250 S Collegeville Rd
Up4420
Collegeville, PA 19426
Phone+1 610-917-5256

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Tufts Medical CenterResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996

Certifications & Licensure

PA State Medical License 2007 - 2026
MA State Medical License 2000 - 2009
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Publications & Presentations

PubMed

5 citations
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
Mikkael A Sekeres, Pau Montesinos, Jan Novak, Jianxiang Wang, Deepa Jeyakumar
Leukemia. 2023-10-01
2 citations
Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies.
Ana Ruiz-Garcia, Naveed Shaik, Swan Lin, Catriona Jamieson, Michael Heuser
Journal of Clinical Pharmacology. 2021-03-01
5 citations
Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers.
Naveed Shaik, Robert R. LaBadie, Brian Hee, Geoffrey Chan
Cancer Chemotherapy and Pharmacology. 2021-01-03

Abstracts/Posters

Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid LeukemiaClinically Relevant Abstract
Geoffrey Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Mye...
Geoffrey Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

New Options in Glaucoma: How MIGS Is Changing the Treatment ParadigmMarch 20th, 2023